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Instructions for Emerging
Infectious Diseases Authors
Letters 
Letters commenting on recent arti-
cles as well as letters reporting
cases, outbreaks, or original
research are welcome. Letters com-
menting on articles should contain
no more than 300 words and 5 ref-
erences; they are more likely to be
published if submitted within 4
weeks of the original article's publi-
cation. Letters reporting cases, out-
breaks, or original research should
contain no more than 800 words
and 10 references. They may have
one Figure or Table and should not
be divided into sections. All letters
should contain material not previ-
ously published and include a word
count.
Correction, vol. 10, no. 10
In "Scrub Typhus in the Republic of Palau, Micronesia," by A.
Mark Durand et al. (p. 1840), Table 2 was incorrect. The correct version
appears below and online at http://www.cdc.gov/ncidod//eid/vol10no10/
04-0288.htm#table2. We regret any confusion this error may have
caused.
Use of trade names is for identification
only and does not imply endorsement by
the Public Health Service or by the U.S.
Department of Health and Human
Services.